Lifevantage Corporation
LFVN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.72M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $65.72 Million |
|---|---|
| Enterprise Value | $60.66 Million |
| Annual dividend | $0.19 |
| Dividend yield | 3.64% |
| Earnings per Share | $0.4 |
| Beta | 0.74 |
| Outstanding Shares | 12,534,000 |
Return
| Return on Equity | 19.02% |
|---|---|
| Return on Assets | 10.28% |
| Return on Invested Capital | 8.82% |
Valuation & Multiples
| P/E Ratio | 13.05 |
|---|---|
| PEG | -37.6 |
| Price to Sales | 0.35 |
| Price to Book Ratio | 2.61 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | 16.43 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$40.49 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 427.13% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.84%▼ 23.36% |
|---|---|
| Total Invested | $18.83M▼ 49.00% |
| Investors Holding | 22▼ 73.00% |
About Lifevantage Corporation
CEO: Darren Jensen
LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...